Various novel biomarkers such as NGAL (Neutrophil gelatinase-associated lipocalin), KIM-1 (Kidney Injury Molecule-1), interleukin-18 and cystatin C have been developed to assist early diagnosis, differential diagnosis and prognostic prediction in patients with AKI [39], [40]. This evidence concerns the gene IL18 and acute kidney injury.